Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy and their caregivers: a post hoc analysis of an international survey.

IF 2.8 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Frontiers in Cardiovascular Medicine Pub Date : 2025-06-09 eCollection Date: 2025-01-01 DOI:10.3389/fcvm.2025.1595797
Francesco Cappelli, Lucia Ponti, Kristen Hsu, Thibaud Damy, Eduardo Villacorta, Nicolas Verheyen, Denis Keohane, Ronnie Wang, Monica Ines, Nisith Kumar, Carmen Munteanu
{"title":"Predictors of disease burden in patients with untreated transthyretin amyloid cardiomyopathy and their caregivers: a <i>post hoc</i> analysis of an international survey.","authors":"Francesco Cappelli, Lucia Ponti, Kristen Hsu, Thibaud Damy, Eduardo Villacorta, Nicolas Verheyen, Denis Keohane, Ronnie Wang, Monica Ines, Nisith Kumar, Carmen Munteanu","doi":"10.3389/fcvm.2025.1595797","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive condition with debilitating symptoms. The self-reported burden of ATTR-CM on patients and their caregivers was previously evaluated in an international, multicenter, real-world survey study.</p><p><strong>Methods: </strong>This <i>post hoc</i> analysis used univariate and multivariate models to evaluate survey items as predictors of ATTR-CM burden. The final multivariate models were optimized using forward selection and CV Press criteria with 8-fold cross-validation to include only the best predictors. Hierarchical linear regression analyses were used to explore potential moderators of the relationship between patient health status and caregiver burden.</p><p><strong>Results: </strong>The original survey included 208 patients with ATTR-CM, naïve to disease-modifying treatment, and their unpaid primary caregivers from international amyloidosis centers of excellence in 7 countries between July 2021 and August 2022. Most patients were male (86%), elderly (median age, 81 years), and had untreated wild-type ATTR-CM (91% of 155 with genetic testing). Patients reported fair to good health status overall [Kansas City Cardiomyopathy Questionnaire Overall Summary (KCCQ-OS) median score, 68]. Most (60%) of the 199 patients with a New York Heart Association (NYHA) classification were class II (18% class I; 22% class III). Optimized multivariate models for several measures found symptomatic heart failure (NYHA class II or III), having \"weakness, especially in the legs,\" older age, and female sex, were independent predictors of higher patient-reported burden. The majority of caregivers were female (85%) and the spouse (59%) or adult child (37%) of the patient. The median duration of caregiving was 1.5 years. In the final optimized multivariate model, only the patient's KCCQ-OS score was a significant predictor of caregiver burden. This relationship was not clinically moderated by other patient or caregiver variables.</p><p><strong>Conclusions: </strong>Our analysis showed that heart failure symptoms, weakness, especially in the legs, older age, and female sex, are independent predictors of higher disease burden in patients with ATTR-CM. A higher caregiver burden was best predicted by poorer health status in the patient, even in the presence of potential moderators. Implementing strategies to reduce the physical symptoms experienced by patients with ATTR-CM may help to reduce their burden, and that experienced by caregivers.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1595797"},"PeriodicalIF":2.8000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12183217/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1595797","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive condition with debilitating symptoms. The self-reported burden of ATTR-CM on patients and their caregivers was previously evaluated in an international, multicenter, real-world survey study.

Methods: This post hoc analysis used univariate and multivariate models to evaluate survey items as predictors of ATTR-CM burden. The final multivariate models were optimized using forward selection and CV Press criteria with 8-fold cross-validation to include only the best predictors. Hierarchical linear regression analyses were used to explore potential moderators of the relationship between patient health status and caregiver burden.

Results: The original survey included 208 patients with ATTR-CM, naïve to disease-modifying treatment, and their unpaid primary caregivers from international amyloidosis centers of excellence in 7 countries between July 2021 and August 2022. Most patients were male (86%), elderly (median age, 81 years), and had untreated wild-type ATTR-CM (91% of 155 with genetic testing). Patients reported fair to good health status overall [Kansas City Cardiomyopathy Questionnaire Overall Summary (KCCQ-OS) median score, 68]. Most (60%) of the 199 patients with a New York Heart Association (NYHA) classification were class II (18% class I; 22% class III). Optimized multivariate models for several measures found symptomatic heart failure (NYHA class II or III), having "weakness, especially in the legs," older age, and female sex, were independent predictors of higher patient-reported burden. The majority of caregivers were female (85%) and the spouse (59%) or adult child (37%) of the patient. The median duration of caregiving was 1.5 years. In the final optimized multivariate model, only the patient's KCCQ-OS score was a significant predictor of caregiver burden. This relationship was not clinically moderated by other patient or caregiver variables.

Conclusions: Our analysis showed that heart failure symptoms, weakness, especially in the legs, older age, and female sex, are independent predictors of higher disease burden in patients with ATTR-CM. A higher caregiver burden was best predicted by poorer health status in the patient, even in the presence of potential moderators. Implementing strategies to reduce the physical symptoms experienced by patients with ATTR-CM may help to reduce their burden, and that experienced by caregivers.

未经治疗的转甲状腺蛋白淀粉样心肌病患者及其护理人员疾病负担的预测因素:一项国际调查的事后分析
转甲状腺素淀粉样心肌病(atr - cm)是一种进行性疾病,伴有衰弱症状。atr - cm对患者及其护理人员的自我报告负担先前在一项国际、多中心、真实世界的调查研究中进行了评估。方法:采用单变量和多变量模型进行事后分析,评估调查项目对atr - cm负担的预测作用。最终的多变量模型使用正向选择和CV Press标准进行优化,并进行8倍交叉验证,以仅包括最佳预测因子。采用层次线性回归分析探讨患者健康状况与照顾者负担之间关系的潜在调节因子。结果:最初的调查包括2021年7月至2022年8月期间来自7个国家的国际淀粉样变卓越中心的208名atr - cm患者,naïve进行疾病改善治疗,以及他们的无偿主要护理人员。大多数患者为男性(86%),老年人(中位年龄81岁),未经治疗的野生型atr - cm(155例基因检测中的91%)。患者报告的总体健康状况一般到良好[堪萨斯城心肌病问卷总体总结(KCCQ-OS)中位得分为68]。199例纽约心脏协会(NYHA)分类的患者中,大多数(60%)为II级(18%为I级;22% III类)。多项措施的优化多变量模型发现,症状性心力衰竭(NYHA II级或III级)、“虚弱,特别是腿部”、年龄较大和女性是患者报告负担较高的独立预测因素。大多数照顾者是女性(85%)和患者的配偶(59%)或成年子女(37%)。护理的中位持续时间为1.5年。在最终优化的多变量模型中,只有患者的KCCQ-OS评分是护理人员负担的显著预测因子。这种关系在临床上不受其他患者或护理人员变量的影响。结论:我们的分析表明,心力衰竭症状、虚弱(尤其是腿部)、年龄和女性是atr - cm患者更高疾病负担的独立预测因素。较高的照顾者负担最好由患者较差的健康状况来预测,即使存在潜在的调节者。实施减轻atr - cm患者身体症状的策略可能有助于减轻患者和护理人员的负担。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine Medicine-Cardiology and Cardiovascular Medicine
CiteScore
3.80
自引率
11.10%
发文量
3529
审稿时长
14 weeks
期刊介绍: Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers? At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信